Tuesday, July 8, 2025
16 C
London

Search results for: Bharat Biotech

For children aged 2 to 18, India’s expert group on COVID-19 recommends Bharat Biotech’s Covaxin

The COVID-19 Subject Expert Committee of the Indian government has endorsed Bharat Biotech's Covaxin for children aged 2 to 18.

Bharat Biotech announces Covaxin price; Rs 600 for states, Rs 1200 for private hospitals

Besides Covaxin, India approved the EUA for two other vaccines Covishield and Sputnik V for its inoculation program against...

Air India carries the first consignment of Bharat Biotech Covid vaccine

The first consignment of Covaxin developed by Bharat Biotech is being carried from Hyderabad to Delhi The first consignment of...

Union Minister of Health & Family Welfare Dr Mansukh Mandaviya virtually addresses the Vibrant Gujarat Pre-Summit on ‘Biotechnology: The Path of Innovation & Wellness...

“India's 'Bio-Economy' has grown eight times in the last eight years from $10 billion to $80 billion. In the coming times, biotechnology will become the biggest foundation for health treatment.”

Union Minister Jitendra Singh refers to an integrated strategy to achieve ‘TB Mukt Bharat’:

Dr Jitendra Singh yesterday announced integrated strategy to achieve 'TB Mukt Bharat' and said, the Department of Biotechnology, which gave the world first DNA vaccine against Covid

Foreign heads to visit biotech companies in Hyderabad

Over 60 envoys to visit biotech companies in Hyderabad developing COVID-19 vaccine New Delhi : More than 60 foreign heads...

Three more Covid vaccines approved in India! Here is how they work

India has approved two Covid vaccines and one Covid pill on December 28. Thus, a total of eight Covid vaccines have got emergency use authorization.

Antibodies in persons who received Covaxin declined after 2 months: Study

Antibodies in persons who received Covishield declined after 3 months A recent study by ICMR-regional medical research centre (RMRC), Bhubaneswar...

DCGI approves ZyCoV-D for emergency use, first one for kids above 12 years

ZyCoV-D is the world's first plasmid DNA needle-free vaccine made by Zydus Cadila in partnership with the Department of...

Zydus Cadila seeks emergency use authorization for the COVID-19 vaccine

Zydus seeks authorisation for ZyCoV-D COVID-19 vaccine for 12 years and above for emergency use New Delhi : Pharmaceutical...

Centre Books 30 Crore Doses of the Hyderabad-based Biological-E’s Covid vaccine

Biological-E's vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, said the...

‘Myths & Facts on India’s Vaccination Process’: GoI responds to allegations concerning COVID-19 vaccination

COVID-19 Vaccines are in limited supply globally, and companies have their own priorities, game plans, and compulsions in allocating...